Impaired cell surface expression of human CD1d by the formation of an HIV-1 Nef/CD1d complex

被引:75
作者
Cho, S
Knox, KS
Kohli, LM
He, JJ
Exley, MA
Wilson, SB
Brutkiewicz, RR
机构
[1] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA
[2] Indiana Univ, Sch Med, Div Pulm Med, Indianapolis, IN 46202 USA
[3] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA
[4] Walther Oncol Ctr, Indianapolis, IN 46202 USA
[5] Walther Canc Inst, Indianapolis, IN 46208 USA
[6] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Canc Biol Program,Div Hematol & Oncol, Boston, MA 02215 USA
[7] Massachusetts Gen Hosp, Diabet Res Labs, Cambridge, MA 02139 USA
基金
美国国家卫生研究院;
关键词
CD1d; human; murine; HIV-1; Nef; cell surface expression; complex;
D O I
10.1016/j.virol.2005.04.020
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The HIV-1 Nef protein causes a decrease in major histocompatibility complex (MHC) class 1 and CD4 molecule expression on the cell surface. To determine if Nef can affect components of the innate immune response, we assessed the ability of Nef to alter the cell surface expression of human CD1d. In cells co-expressing CD1d and Nef, a Substantial reduction in the cell surface level of CD1d was observed, with a concomitant reduction in the activation of CD1d-restricted NKT cells. Nef had a minimal effect on the cell surface expression of a mutant CD1d molecule in which the last 6 or 10 amino acids of the cytoplasmic tail were deleted. Additionally, it was found that Nef physically interacted with wild-type (but not tail-deleted) CD1d. Therefore, one means by which HIV-1 may be able to establish a foothold in an infected individual is by directly interfering with the functional cell surface expression of CD1d. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:242 / 252
页数:11
相关论文
共 76 条
[1]   NEF INDUCES CD4 ENDOCYTOSIS - REQUIREMENT FOR A CRITICAL DILEUCINE MOTIF IN THE MEMBRANE-PROXIMAL CD4 CYTOPLASMIC DOMAIN [J].
AIKEN, C ;
KONNER, J ;
LANDAU, NR ;
LENBURG, ME ;
TRONO, D .
CELL, 1994, 76 (05) :853-864
[2]  
BACIK I, 1994, J IMMUNOL, V152, P381
[3]   TUBERCULOSIS IN PATIENTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
BARNES, PF ;
BLOCH, AB ;
DAVIDSON, PT ;
SNIDER, DE .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (23) :1644-1650
[4]  
Bonifacino JS, 1996, P ASSOC AM PHYSICIAN, V108, P285
[5]   Molecular bases for the recognition of tyrosine-based sorting signals [J].
Bonifacino, JS ;
Dell'Angelica, EC .
JOURNAL OF CELL BIOLOGY, 1999, 145 (05) :923-926
[6]   CD1d-mediated recognition of an α-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution [J].
Brossay, L ;
Chioda, M ;
Burdin, N ;
Koezuka, Y ;
Casorati, G ;
Dellabona, P ;
Kronenberg, M .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (08) :1521-1528
[7]   Natural killer T (NKT) cells and their role in antitumor immunity [J].
Brutkiewicz, RR ;
Sriram, V .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2002, 41 (03) :287-298
[8]   CD1d-mediated antigen presentation to natural killer T (NKT) cells [J].
Brutkiewicz, RR ;
Lin, YL ;
Cho, SY ;
Hwang, YK ;
Sriram, V ;
Roberts, TJ .
CRITICAL REVIEWS IN IMMUNOLOGY, 2003, 23 (5-6) :403-419
[9]   TAP-INDEPENDENT, BETA(2)-MICROGLOBULIN-DEPENDENT SURFACE EXPRESSION OF FUNCTIONAL-MOUSE CD1.1 [J].
BRUTKIEWICZ, RR ;
BENNINK, JR ;
YEWDELL, JW ;
BENDELAC, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (06) :1913-1919
[10]  
CAMAUD C, 1999, J IMMUNOL, V163, P4647